Compare with GF CSI Medical ETF
Key stats
Details
Home page
Inception date
Sep 6, 2023
Structure
Open-Ended Fund
Replication method
Synthetic
Dividend treatment
Distributes
Primary advisor
GF Fund Management Co., Ltd.
ISIN
CNE1000067W3
FIGI
BBG01J2RV2R7
Identifiers
ISIN CNE1000067W3
Functions as an exchange traded fund
Classification
What's in the fund
Exposure type
Health Technology
Health Services
Breakdown by region
Top 10 holdings
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
560260 trades at 0.836 CNY today, its price has risen 1.83% in the past 24 hours. Track more dynamics on 560260 price chart.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
560260 invests in stocks. See more details in our Profile section.
560260 expense ratio is 0.55%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, 560260 isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, 560260 technical analysis shows the strong buy rating and its 1-week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating 560260 shows the sell signal. See more of 560260 technicals for a more comprehensive analysis.
Today, 560260 technical analysis shows the strong buy rating and its 1-week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating 560260 shows the sell signal. See more of 560260 technicals for a more comprehensive analysis.
No, 560260 doesn't pay dividends to its holders.
560260 shares are issued by GF Securities Co., Ltd.
560260 follows the CSI Medical Index Yield - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Sep 6, 2023.
The fund's management style is passive, meaning it's aiming to replicate the performance of the underlying index by holding assets in the same proportions as the index. The goal is to match the index's returns.